Patent details

EP3711776 Title: MODIFIED HOST CELLS AND USES THEREOF

Basic Information

Publication number:
EP3711776
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP201700903
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MODIFIED HOST CELLS AND USES THEREOF
French Title of Invention:
CELLULES HÔTES MODIFIÉES ET LEURS UTILISATIONS
German Title of Invention:
MODIFIZIERTE WIRTSZELLEN UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
13/10/2014
Grant date:
11/01/2023
EP Publication Date:
23/09/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/01/2023
EP B1 Publication Date:
11/01/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/10/2023
Expiration date:
13/10/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/01/2023
 
 

Name:
GlaxoSmithKline Biologicals SA
Address:
Rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

Inventor

1

Name:
KEMMLER, Stefan J
Address:
Switzerland (CH)

2

Name:
FERON, Christiane Marie-Paule Simone Jeanne
Address:
Belgium (BE)

3

Name:
QUÉBATTE, Julien L
Address:
Switzerland (CH)

4

Name:
KOWARIK, Michael
Address:
Switzerland (CH)

Priority

Priority Number:
201461980988 P
Priority Date:
17/04/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/104; C07K 14/21; C12N 15/70; C12N 5/10;

Publication

European Patent Bulletin

Issue number:
202302
Publication date:
11/01/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages